| PTIE Shares Outstanding History Table | ||||||||||||||||
Below is a table of the PTIE shares outstanding history going back to 5/10/2017:
Also see: PTIE Market Cap History PTIE YTD Return |
As of 10/26/2018 Pain Therapeutics has 17.22 million PTIE shares outstanding. Investors often track the PTIE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PTIE share count trends over time, with 7 historical shares outstanding datapoints presented, dating back to 5/10/2017.

| PTIE Shares Outstanding History Table | ||||||||||||||||
Below is a table of the PTIE shares outstanding history going back to 5/10/2017:
Also see: PTIE Market Cap History PTIE YTD Return |
| PTIE Shares Outstanding History Chart | |||||||||||||||||
PTIE Historical Shares Outstanding: +92.77% CAGR
Mouse over chart for data details
| |||||||||||||||||
| PTIE Stock Price Chart |
| About Cassava Sciences Inc |
| Cassava Sciences engages in developing proprietary drugs for patients and healthcare professionals, and focuses its drug development efforts on disorders of the nervous system, such as chronic pain. Co.'s primary drug candidate, REMOXY, is a proprietary, abuse-deterrent, oral formulation of oxycodone developed to make oxycodone difficult to abuse yet provide pain relief. Co.'s other drug candidate, FENROCK, is a proprietary, abuse-deterrent skin patch to treat severe pain. In addition, Co. has worldwide rights to PTI-125, a small molecule drug candidate designed to treat Alzheimer's Disease and other neurological disorders. We show 7 historical shares outstanding datapoints in our coverage of PTIE's shares outstanding history. Understanding the changing numbers of PTIE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PTIE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PTIE by allowing them to research PTIE shares outstanding history as well as any other stock in our coverage universe. |
| PTIE Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| PTIE Share Performance |
| Shares Outstanding Peers |
| Pain Therapeutics (PTIE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PTIX Shares Outstanding History PTLA Shares Outstanding History PTN Shares Outstanding History PTPI Shares Outstanding History PTX Shares Outstanding History PULM Shares Outstanding History PXMD Shares Outstanding History PYXS Shares Outstanding History QCLS Shares Outstanding History QDEL Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.